STEVENS-JOHNSON SYNDROME
Clinical trials for STEVENS-JOHNSON SYNDROME explained in plain language.
Never miss a new study
Get alerted when new STEVENS-JOHNSON SYNDROME trials appear
Sign up with your email to follow new studies for STEVENS-JOHNSON SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare, Life-Threatening skin conditions?
Disease control CompletedThis study tested the drug tofacitinib in 20 adults with Stevens-Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN), rare and severe skin reactions. The main goal was to see how quickly the skin healed completely. Researchers also tracked hospital stays, deaths, side effe…
Matched conditions: STEVENS-JOHNSON SYNDROME
Phase: NA • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated May 26, 2026 06:16 UTC
-
Could a white blood cell booster heal deadly skin reactions faster?
Disease control CompletedThis study tested a drug called G-CSF to see if it helps people with a severe, life-threatening skin reaction called toxic epidermal necrolysis heal faster. Ten patients were randomly assigned to receive either G-CSF or a placebo for five days. The main goal was to measure how qu…
Matched conditions: STEVENS-JOHNSON SYNDROME
Phase: PHASE4 • Sponsor: University of Liege • Aim: Disease control
Last updated May 26, 2026 06:12 UTC
-
New hope for rare skin crisis: drug may speed healing
Disease control CompletedThis study tested a drug called etanercept against a placebo in adults with severe skin reactions (Stevens-Johnson syndrome or toxic epidermal necrolysis). The goal was to see if the drug helps skin heal faster and to collect samples to find better ways to diagnose and treat the …
Matched conditions: STEVENS-JOHNSON SYNDROME
Phase: PHASE3 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated May 26, 2026 04:38 UTC